Europe Organ Preservation Market (2025-2030)
The Europe Organ Preservation Market was valued at $0.62 Million in 2025 and projected to reach to $0.79 Million by 2030, representing a compound annual growth rate of 5.2%. Europe's organ preservation market is poised for steady expansion, supported by aging populations requiring transplants and investments in healthcare infrastructure across major economies.
Europe Organ Preservation Market Trends and Insights
- GCC Countries' healthcare infrastructure investments and increasing transplant procedures are driving adoption of advanced organ preservation technologies.
- The region's focus on improving transplant outcomes and reducing organ rejection rates positions GCC Countries as a growing market for preservation solutions..
Key Market Statistics
- CAGR (2025-2030) 5.2% CAGR
- Market Size, 2025 ~USD 0.62 Million
- Forecast, 2030 ~USD 0.79 Million
- Geography Europe
Europe Organ Preservation Market Overview
Strong Market Leadership :
Germany leads Europe's organ preservation market with $13.52 million in 2025, driven by advanced healthcare infrastructure and high transplant volumes across major medical centers.
Regulatory Excellence :
Europe's stringent regulatory frameworks and CE marking requirements ensure adoption of only the most reliable organ preservation technologies, supporting market credibility and safety standards.
Growing Transplant Demand :
Increasing organ transplant procedures across France, Spain, and Italy are accelerating demand for advanced preservation solutions to improve graft survival rates and patient outcomes.
Innovation Hub :
European research institutions and medical device manufacturers are driving technological advancements in normothermic and hypothermic preservation systems, positioning the region as a global innovation leader.
Europe Organ Preservation Market Dynamics
- Germany, France, and Spain are key growth drivers, with increasing adoption of advanced preservation technologies to enhance transplant success rates.
- The region's commitment to improving organ allocation efficiency and reducing cold ischemia time is accelerating market penetration.
- By 2030, Europe is expected to maintain its position as a mature, innovation-driven market with sustained demand for next-generation preservation solutions..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- GCC Countries organ preservation market valued at $0.62M in 2025, growing to $0.79M by 2030
- GCC Countries demonstrates a 5.2% CAGR, reflecting steady regional healthcare advancement
- GCC Countries' investment in transplant infrastructure supports market expansion through 2030
- GCC Countries' focus on organ viability and transplant success drives technology adoption
Organ Preservation Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PERFADEX (Solution) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.8% from 2025 to 2030 |
| Largest Segment | ORGAN TRANSPLANT CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.22 (2025) |
| Revenue Forecast (Billions) | ~USD 0.3 (2030) |
| Segments Covered | Solution, Technique, Organ Type, End User |
Europe Organ Preservation Market Report Segmentation
4 segment dimensions are covered across the global market.
By Solution
- Custodiol Htk
- Other Solutions
- Perfadex
- University Of Wisconsin Solution
By Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Static Cold Storage
By Organ Type
- Heart
- Kidneys
- Liver
- Lungs
- Other Organs
By End User
- Hospitals
- Organ Transplant Centers
- Specialty Clinics
Target Audience
- Medical Device Manufacturers : Require detailed European market segmentation, regulatory pathways, and competitive positioning to develop go-to-market strategies and optimize product portfolios for regional demand.
- Healthcare Investors & PE Firms : Need comprehensive market sizing, growth forecasts, and investment opportunities across European organ preservation companies and emerging technology platforms.
- Hospital & Transplant Center Administrators : Seek technology benchmarking, cost-benefit analyses, and procurement insights to evaluate organ preservation solutions and improve transplant program outcomes.
- Regulatory & Compliance Consultants : Require country-specific regulatory intelligence, approval timelines, and compliance requirements to guide medical device companies through European market authorization.
- Strategic Business Planners : Need market intelligence on European healthcare trends, transplant volumes, and technology adoption patterns to inform long-term business development and expansion strategies.
Key Companies in the Europe Organ Preservation Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Static Cold Storage–linked care (all solutions),Hypothermic machine perfusion–linked care,Normothermic perfusion–linked care, |
| XVIVO PERFUSION AB | Sweden | Public Company | Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions, |
| TRANSMEDICS, INC. | United States | Public Company | OCS Heart,OCS Lung,OCS Liver, |
| BIOLIFE SOLUTIONS, INC. | United States | Public Company | HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport), |
| SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms), |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.
XVIVO PERFUSION AB
XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.
TRANSMEDICS, INC.
TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.
BIOLIFE SOLUTIONS, INC.
BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 13.52 Million |
| France | USD 9.06 Million |
| UK | USD 7.64 Million |
| Spain | USD 10.71 Million |
| Italy | USD 6.69 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Insights : Detailed analysis of Germany, France, UK, Spain, and Italy markets with specific sizing, growth trajectories, and competitive landscapes tailored to European healthcare systems.
- Regulatory & Compliance Framework : Comprehensive understanding of CE marking requirements, EU medical device regulations, and country-specific approval pathways essential for market entry and product commercialization.
- Competitive Landscape Mapping : Identification of leading European manufacturers, emerging players, and partnership opportunities within the region's organ preservation ecosystem.
- Growth Opportunity Assessment : Strategic insights into high-growth segments, underserved markets, and emerging technologies driving adoption across European transplant centers and hospitals.
- Investment & Expansion Strategy : Data-driven recommendations for market entry, geographic prioritization, and resource allocation across Europe's most promising organ preservation markets.
Frequently asked questions
What is the current size of the organ preservation market in GCC Countries?
The organ preservation market in GCC Countries is estimated at $0.62 million in 2025.
What is the projected market size for organ preservation in GCC Countries by 2030?
GCC Countries' organ preservation market is forecasted to reach $0.79 million by 2030.
What is the CAGR for the organ preservation market in GCC Countries?
GCC Countries' organ preservation market is expected to grow at a compound annual growth rate of 5.2% from 2025 to 2030.
What factors are driving growth in GCC Countries' organ preservation market?
Growth in GCC Countries is driven by increased transplant procedures, healthcare infrastructure investments, and emphasis on improving organ viability and transplant outcomes.
How does GCC Countries' market performance compare to global trends?
GCC Countries' 5.2% CAGR reflects steady regional growth, supported by advancing healthcare capabilities and rising demand for organ preservation solutions.
RESEARCH METHODOLOGY
The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.
This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.
Primary Research
Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the organ preservation market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach
Data Triangulation
The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.
Market Definition
Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.
Stakeholders
- Association of Organ Procurement Organizations (AOPO)
- American Transplant Congress (ATC)
- United Network for Organ Sharing (UNOS)
- Network & Alliance of Transplant Coordinators (NATCO)
- Consortium for Organ Preservation in Europe (COPE)
- European Society for Organ Transplantation (ESOT)
- Asian Society of Transplantation (AST)
- National Health Service (UK NHS)
- International Registry on Organ Donation and Transplantation (IRODaT)
- Global Observatory on Donation and Transplants (GODT)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
- Organisation for Economic Co-operation and Development (OECD)
- Centers for Disease Control and Prevention (CDC)
- Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
- White Papers, Journals/Magazines, and News Articles
Report Objectives
- To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
- To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering
Get the Full Organ Preservation Market Report
Full forecast, segment splits, and company analysis for all Organ Preservation Market.
- US Organ Preservation Market
- Canada Organ Preservation Market
- Germany Organ Preservation Market
- France Organ Preservation Market
- UK Organ Preservation Market
- Spain Organ Preservation Market
- Italy Organ Preservation Market
- China Organ Preservation Market
- Japan Organ Preservation Market
- India Organ Preservation Market
- Australia Organ Preservation Market
- South Korea Organ Preservation Market
- Brazil Organ Preservation Market
- Mexico Organ Preservation Market
- GCC Countries Organ Preservation Market
- Roe Organ Preservation Market
- Rest Of Asia Pacific Organ Preservation Market
- Rest Of Europe Organ Preservation Market
- Rest Of Latin America Organ Preservation Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report